CO92 Comparative Effectiveness of Second-Line Immune Targeted Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Network Meta-Analysis
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.180
https://www.valueinhealthjournal.com/article/S1098-3015(24)00295-X/fulltext
Title :
CO92 Comparative Effectiveness of Second-Line Immune Targeted Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00295-X&doi=10.1016/j.jval.2024.03.180
First page :
Section Title :
Open access? :
No
Section Order :
11217